Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108129373B details a novel 3-step palladium-catalyzed route for diaryl pyrroles, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN111393427A reveals a safer, high-yield synthesis for pyroxasulfone intermediates, offering significant cost reduction and supply chain reliability for global herbicide manufacturers.
Novel MOF-Cu catalyzed Ugi reaction for high-purity dipeptide intermediates. Cost-effective, scalable synthesis with reusable catalyst for pharmaceutical applications.
Patent CN111170847B reveals a cyanide-free route for Drotaverine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Patent CN108440623A reveals a novel silylation-free route for Capecitabine Intermediate. Achieve higher purity and reduced manufacturing costs with scalable supply.
Novel continuous synthesis method for high-purity 3-methyl-3-butene-1-alcohol. Reduces pressure and temperature while enhancing supply chain reliability for global buyers.
Patent CN109761975B reveals a catalyst-free aminomethylation route for imidazoheteroaryls, offering significant cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN105273006B details a high-yield synthesis route for advanced ligands. This method ensures high purity and simplified processing for reliable pharmaceutical intermediates supply chains.
Patent CN113004326B discloses advanced bidentate phosphine ligands enhancing adipaldehyde selectivity up to 60%, offering a viable route for nylon precursors.
Patent CN114621128A reveals a novel TBS-protection strategy for (S)-oxiracetam, eliminating column chromatography to ensure >99.9% purity and significant cost reduction.
Patent CN101417910A details solid acid catalysis for prazole nitration, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed route for baloxavir intermediate. Safer, scalable, cost-effective manufacturing solution for global supply chains.
Novel catalytic amination process for ethacridine reduces waste and improves purity. Ideal for pharmaceutical supply chains seeking cost-effective API manufacturing solutions.
Novel process for 1H-imidazo[4,5-c]quinoline-4-amine via cyano intermediates. High purity, scalable route for API manufacturing avoiding harsh conditions.
Patent CN106928191B reveals improved Lansoprazole production with higher purity and yield. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107793325A reveals a green boric acid catalyzed route for synthetic capsaicin, offering high purity and reduced environmental impact for supply chains.
Novel patent CN110878104B details a safer two-step route for chiral 1,2-bis(2,5-diphenylphosphino)ethane, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN105906680A reveals high-yield desogestrel route exceeding 90% total yield. This technology reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113105502B reveals a safer, high-yield route for tert-butyldiphenylphosphine using tert-butanol, offering significant cost reduction and supply chain stability for pharma intermediates.
Patent CN112694487B details a novel silanization route for Cefprozil, ensuring European Pharmacopoeia compliance and superior impurity control for global supply chains.